|
|
||||||||
Harvard Medical School, Boston, Massachusetts
Correspondence: 1 For reprints contact: Eileen W. Prince, Joint Program in Nuclear Medicine, 50 Binney St., Boston, Mass. 02115.
ABSTRACT
The recent development of 99mTc-tetracycline in our laboratory and its successful use in delineating myocardial infarcts have encouraged further investigation into the mechanism of its uptake and its localization on a subcellular level. The affinity of 99mTc for cells and subcellular constituents when incubated with 99mTc-tetracycline was evaluated in our recently developed necrosis model of tissue culture. Live cells obtained from exponentially growing cultures or dead cells obtained from the media of nutritionally depleted plateau-phase cultures were incubated with 99mTc-tetracycline at 37°C for various times. After incubation, the cells were washed and the total cellular activity as well as the sub-cellular localization of 99mTc determined. About 60 times more 99mTc remained associated with the dead cells than with the live cells. This affinity was not seen when the dead cells were incubated with the pertechnetate ion. On the sub-cellular level, at least 50% of the 99mTc appeared to be associated with the DNA and protein fractions of the cell. This system may provide a rapid and economical means of screening radioactive compounds currently being prepared to detect necrotic tissue.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |